Aegerion Pharmaceuticals, Inc. 4
4 · Aegerion Pharmaceuticals, Inc. · Filed Aug 20, 2014
Insider Transaction Report
Form 4
Fitzpatrick Mark J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2014-08-19$30.64/sh+1,150$35,236→ 9,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.57 to $30.68, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.